Turning Point Brands AI Stock Analysis
Want to see TPB full AI Analyst Report?
Turning Point Brands (TPB) AI Stock Analysis
Turning Point Brands
(NYSE:TPB)
The score is driven primarily by pressured profitability and weaker cash-conversion despite revenue growth and an improving balance sheet. Technicals are neutral with longer-term trend weakness, and valuation is a meaningful drag due to a high P/E and low dividend yield. The latest earnings call adds support via strong Modern Oral momentum and maintained guidance, but is tempered by the sharp EBITDA decline and timing/FDA-related uncertainty.
Turning Point Brands (TPB) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.10B
- Dividend Yield
- 0.57%
- Average Volume (3M)
- 387.75K
- Price to Earnings (P/E)
- 39.1
- Beta (1Y)
- 0.64
- Revenue Growth
- 23.78%
- EPS Growth
- -51.37%
- Country
- US
- Employees
- 484
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Tobacco
Turning Point Brands Business Overview & Revenue Model
Company Description
Turning Point Brands, Inc., along with its affiliated companies, is engaged in the creation, promotion, and distribution of a diverse array of branded consumer products. Its operations are structured into three distinct divisions: Zig-Zag Products, S...
How the Company Makes Money
TPB makes money by selling branded tobacco and nicotine products and related accessories into retail and wholesale distribution. The company’s core revenue model is product sales (shipments) to distributors and retailers, with earnings driven by a co...
Turning Point Brands Earnings Call Summary
The call was predominantly positive. Modern Oral delivered triple-digit year-over-year growth, distribution expanded rapidly, FRE and ALP showed encouraging retail momentum, liquidity remained strong, and full-year guidance was maintained. The main negatives were the 41% year-over-year adjusted EBITDA decline, lower Zig-Zag sales, Stoker's gross-margin contraction, and uncertainty around fourth-quarter timing and FDA-dependent manufacturing commencement.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
The company remains confident in achieving its full year outlook provided on September 21, 2026: Modern Oral gross sales guidance is $330 million to $350 million, net sales guidance is $260 million to $270 million, and full year adjusted EBITDA guidance is $70 million to $80 million; it continues to expect an effective income tax rate between 23% to 26% on a go-forward basis, fourth quarter CapEx of $1 million to $2 million excluding projects related to Modern Oral, and roughly $3.5 million of fourth quarter spending in support of its PMTA. The company is on track to increase its chain store count by more than 70% during 2026 and currently expects U.S. manufacturing to commence in 2027.
Turning Point Brands Financial Statement Overview
Summary
Mixed fundamentals: revenue is up meaningfully and gross margin remains strong, and leverage has improved to a more moderate level. However, profitability has compressed sharply (much lower net and EBITDA margins vs prior years) and cash conversion has weakened, which limits the financial performance score.
Income Statement
58NeutralBalance Sheet
72PositiveCash Flow
53Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 539.35M | 463.06M | 360.66M | 325.06M | 321.23M | 445.47M |
| Gross Profit | 314.83M | 264.31M | 201.56M | 182.94M | 177.83M | 217.83M |
| EBITDA | 78.03M | 115.94M | 94.05M | 88.64M | 64.97M | 98.59M |
| Net Income | 27.41M | 58.16M | 39.81M | 38.46M | 11.64M | 52.06M |
Balance Sheet | ||||||
| Total Assets | 846.65M | 763.75M | 493.35M | 569.36M | 572.11M | 601.56M |
| Cash, Cash Equivalents and Short-Term Investments | 251.29M | 222.76M | 46.16M | 117.89M | 106.40M | 128.32M |
| Total Debt | 310.11M | 308.97M | 261.27M | 377.99M | 420.45M | 430.48M |
| Total Liabilities | 396.99M | 391.77M | 302.97M | 417.35M | 458.73M | 467.84M |
| Stockholders Equity | 422.87M | 354.30M | 187.98M | 150.98M | 111.64M | 131.40M |
Cash Flow | ||||||
| Free Cash Flow | 23.85M | 43.84M | 62.44M | 61.17M | 22.59M | 62.06M |
| Operating Cash Flow | 34.31M | 57.37M | 67.06M | 66.88M | 30.27M | 68.22M |
| Investing Cash Flow | -25.56M | -31.67M | -10.51M | -5.91M | -18.79M | -58.84M |
| Financing Cash Flow | 41.22M | 148.27M | -128.15M | -49.51M | -43.30M | 57.07M |
Turning Point Brands Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TPB, the sentiment is Negative. The current price of 55.55 is below the 20-day moving average (MA) of 64.55, below the 50-day MA of 63.60, and below the 200-day MA of 83.70, indicating a bearish trend. The MACD of -1.35 indicates Positive momentum. The RSI at 33.00 is Neutral, neither overbought nor oversold. The STOCH value of 4.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TPB.
Turning Point Brands Risk Analysis
Turning Point Brands disclosed 46 risk factors in its most recent earnings report. Turning Point Brands reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksTurning Point Brands Peers Comparison
Overall Rating
BTI68Neutral
PM68Neutral
MO65Neutral
RLX65Neutral
TPB57Neutral
XXII46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | $132.14B | 15.95 | 13.38% | 5.34% | 4.47% | 117.22% | |
| 68Neutral | $310.11B | 29.05 | -119.68% | 3.02% | 7.91% | 24.06% | |
| 65Neutral | $130.81B | 16.25 | -279.72% | 5.46% | 2.41% | -7.63% | |
| 65Neutral | $1.91B | 13.01 | 6.20% | 7.05% | 59.23% | 39.66% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 57Neutral | $1.10B | 39.12 | 6.97% | 0.57% | 23.78% | -51.37% | |
| 46Neutral | $424.22K | 0.00 | -20.47% | ― | -27.44% | 99.95% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TPB | Turning Point Brands Inc | 55.55 | -44.97 | -44.74% | |
| MO | Altria | 78.64 | 24.19 | 44.43% | |
| BTI | British American Tobacco | 61.89 | 10.25 | 19.86% | |
| PM | Philip Morris International | 198.96 | 51.42 | 34.85% | |
| XXII | 22nd Century Group | 0.77 | -15271.22 | -99.99% | |
| RLX | Rlx Technology, Inc. | 1.56 | -0.85 | -35.38% |
Turning Point Brands Corporate Events
Turning Point Brands Reports Third Quarter 2026 Results
NegativeOn November 9, 2026, Turning Point Brands announced results for the quarter ended September 30, 2026. Consolidated net sales rose 27.0% to $151.1 million and gross profit increased 20.9% to $85.2 million, driven by Modern Oral, whose gross sales clim...
Turning Point Brands Announces CEO Resignation and Successor
NeutralOn September 21, 2026, Turning Point Brands announced that President and CEO Graham Purdy resigned, effective September 30, 2026, for personal reasons unrelated to any dispute with the company or its board. The board appointed long-time director and...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 10, 2026
